Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatitis C virus viral assays in the direct-acting antiviral era.

Clinics in liver disease - 1 Feb 2013

Vierling John M

Abstract excerpt

In the direct-acting antiviral (DAA) era of hepatitis C virus (HCV) therapy, health care providers must be knowledgeable about genotype and subtype of HCV infection and interpretation of quantitative HCV viral assays to monitor treatment responses. They may also choose to assess interleukin 28B genotypes or resistance-associated variants after ineffective DAA therapy. DAA therapies require understanding of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Viral
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis C

Share to Interferons

Share to Interleukins

Share to Limit of Detection

Share to Terminology as Topic

Source

Identifiers

PMID: 23177281
DOI: 10.1016/j.cld.2012.09.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Hepatitis C virus viral assays in the direct-acting antiviral era.PMID 23177281Read ↗

Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response.Semantic proximity Read ↗

Implications of HCV RNA level at week 4 of direct antiviral treatments for hepatitis C.Semantic proximity Read ↗

Use of virologic assays in the diagnosis and management of hepatitis C virus infection.Semantic proximity Read ↗

Development of a Rapid Automated Point-of-Care Test for Hepatitis C Viral RNA on the DASH Rapid Polymerase Chain Reaction System.Semantic proximity Read ↗

Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral-based treatment regimens: Evidence from a global data set.Semantic proximity Read ↗

The importance of HCV RNA measurement for tailoring treatment duration.Semantic proximity Read ↗

HCV Viral Load Greater Than 1000 IU/ml at Time of Virologic Failure in Direct-Acting Antiviral-Treated Patients.Semantic proximity Read ↗

Standard Versus Extended Duration Direct-Acting Antiviral Therapy in Hepatitis C Patients With Slow Response to Treatment.Semantic proximity Read ↗

Comparison of three commercially available assays for HCV RNA using the international unit standard: implications for management of patients with chronic hepatitis C virus infection in clinical practice.Semantic proximity Read ↗

Standardized hepatitis C virus RNA panels for nucleic acid testing assays.Semantic proximity Read ↗

Verification of an assay for quantification of hepatitis C virus RNA by use of an analyte-specific reagent and two different extraction methods.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.